Docetaxel Injection — FDA Drug Shortage

To Be Discontinued — Ingenus Pharmaceuticals LLC

The FDA lists a drug shortage record for Docetaxel Injection (injection) from Ingenus Pharmaceuticals LLC with status To Be Discontinued. The shortage was first posted on Feb 20, 2026.

Shortage details

Status
To Be Discontinued
Company
Ingenus Pharmaceuticals LLC
Package NDC
50742-431-08
Dosage Form
Injection
Presentation
Docetaxel, Injection, 10 mg/1 mL (NDC 50742-431-08)
Initial Posting
Feb 20, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.